# Phase II Study of Ovulation in Obese Women

> **NCT06306131** · PHASE2 · RECRUITING · sponsor: **InnovaGyn, Inc.** · enrollment: 22 (estimated)

## Conditions studied

- Pregnancy Prevention

## Interventions

- **DRUG:** Levonorgestrel 0.15 milligram
- **DRUG:** Meloxicam 15 milligram
- **OTHER:** calcium carbonate 750 milligram

## Key facts

- **NCT ID:** NCT06306131
- **Lead sponsor:** InnovaGyn, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-10
- **Primary completion:** 2025-11-30
- **Final completion:** 2025-11-30
- **Target enrollment:** 22 (ESTIMATED)
- **Last updated:** 2025-08-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06306131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06306131, "Phase II Study of Ovulation in Obese Women". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06306131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*